Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement

Clinical Endocrinology

Volumn 58, Issue 1, 2003, Pages 99-107

  Weissberger, Andrew J ^a   Anastasiadis, Anastasios D ^a   Sturgess, Ian ^a   Martin, Finbarr C ^a   Smith, Michael A ^a   Sönksen, Peter H ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEMOPTYSIS; HUMAN; HYPERTENSION; LEAN BODY WEIGHT; MALE; MUSCLE STRENGTH; PAIN; PERIPHERAL EDEMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; TOTAL HIP PROSTHESIS; WALKING;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BODY COMPOSITION; DOUBLE-BLIND METHOD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ISOMETRIC CONTRACTION; MALE; MIDDLE AGED; MUSCLE, SKELETAL; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RECOMBINANT PROTEINS; WALKING;

EID: 0037236312     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01700.x     Document Type: Article

References (30)

1. Aniansson, A., Rundgren, A. & Sperling, L. (1980) Evaluation of functional capacity in activities of daily living in 70 year old men and women. Scandinavian Journal of Rehabilitation Medicine, 12, 145-154.
2. Bulcke, J.A., Termote, J.L., Palmers, Y. & Crolla, D. (1979) Computed tomography of the human skeletal muscular system. Neuroradiology, 17, 127-136.
3. Cohn, S.H., Vartsky, D., Yasumura, S., Sawitsky, A., Zanzi, I., Vaswani, A. & Ellis, K.J. (1980) Compartmental body composition based on total-body nitrogen, potassium, and calcium. American Journal of Physiology, 239, E524-E530.
4. Corpas, E., Harman, S.M. & Blackman, M.R. (1993) Human growth hormone and human aging. Endocrine Reviews, 14, 20-39.
5. Cuneo, R.C., Salomon, F., Wiles, C.M., Hesp, R. & Sönksen, P.H. (1991) Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. Journal of Applied Physiology, 70, 688-694.
6. Danneskiold-Samsoe, B., Kofod, V., Munter, J., Grimby, G., Schnohr, P. & Jensen, G. (1984) Muscle strength and functional capacity in 78-81 year old men and women. European Journal of Applied Physiology, 52, 310-314.
7. Desai, S.A. & Jacobs, D.O. (1996) Role of growth hormone in the septic, trauma and surgical patient. In Growth Hormone in Critical Illness: Research and Clinical Studies (ed. M. H. Torosian), pp. 119-140. R.G. Landes Company, Austin, Texas.
8. Edwards, R.H.T. & Hyde, S. (1977) Methods of measuring muscle strength and fatigue. Physiotherapy, 63, 51-55.
9. Forbes, G.B. & Reina, J.C. (1970) Adult lean body mass declines with age: Some longitudinal observations. Metabolism: Clinical and Experimental, 19, 653-663.
10. Gamrin, L., Essen, P., Hultman, E., McNurlan, M.A., Garlick, P.J. & Wernerman, J. (2000) Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients. Annals of Surgery, 231, 577-586.
11. Jette, A.M., Harris, B.A., Cleary, P.D. & Campion, E.W. (1987) Functional recovery after hip fracture. Archives of Physical Medicine and Rehabilitation, 68, 735-740.
12. Jorgensen, J.O.L., Pedersen, S.A., Thuesen, L., Jorgensen, J., Ingemann-Hansen, T., Skakkebaek, N.E. & Christiansen, J.S. (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, i, 1221-1225.
13. Kissmeyer-Nielsen, P., Jensen, M.B. & Laurberg, S. (1999) Perioperative growth hormone treatment and functional outcome after major abdominal surgery: A randomized, double-blind, controlled study. Annals of Surgery, 229, 298-302.
14. Magaziner, J., Simonsich, E.M., Hebel, J.R. & Kenzora, J.E. (1990) Predictors of functional recovery one year following discharge for hip fracture: A prospective study. Journal of Gerontology, 45, 101-107.
15. Marcus, R., Butterfield, G., Holloway, L., Gilliland, L., Baylink, D.J., Hintz, R.L. & Sherman, B.M. (1990) Effects of short term administration of recombinant human growth hormone to elderly people. Journal of Clinical Endocrinology and Metabolism, 70, 519-527.
16. Novak, L.P. (1972) Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years. Journal of Gerontology, 27, 438-443.
17. Papadakis, M.A., Grady, D., Black, D., Tierney, M., Gooding, G.A.W., Schambelan, M. & Grunfeld, C. (1996) Growth hormone replacement in healthy older men improves body composition but not functional ability. Annals of Internal Medicine, 124, 708-716.
18. Ross, R.J.M., Miell, J.P. & Buchanan, C.R. (1991b) Avoiding auto-cannibalism. British Medical Journal, 303, 1147-1148.
19. Ross, R.J.M., Miell, J.P., Freeman, E., Jones, J., Matthews, D., Preece, M. & Buchanan, C. (1991a) Critically ill patients have high basal growth hormone concentrations with attenuated oscillatory activity associated with low concentrations of insulin-like growth factor I. Clinical Endocrinology, 35, 47-54.
20. Rudman, D. (1985) Growth hormone, body composition, and aging. Journal of the American Geriatric Society, 33, 800-807.
21. Rudman, D., Feller, A.G., Nagraj, H.S., Gergans, G.A., Lalitha, P.Y., Goldberg, A.F., Schlenker, R.A., Cohn, L., Rudman, I.W. & Mattson, D.E. (1990) Effects of human growth hormone in men over 60 years old. New England Journal of Medicine, 323, 1-6.
22. Rudman, D., Kutner, M.H., Rogers, C.M., Lubin, M.F., Fleming, G.A. & Bain, R.P. (1981) Impaired growth hormone secretion in the adult population: Relation to age and adiposity. Journal of Clinical Investigation, 67, 1361-1369.
23. Rutherford, O.M., Beshyah, S.A. & Johnston, D.G. (1994) Quadriceps strength before and after growth hormone replacement in hypopituitary adults: Relationship to changes in lean body mass and IGF-1. Endocrinology and Metabolism, 1, 41-47.
24. Salomon, F., Cuneo, R.C., Hesp, R. & Sönksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
25. Schambelan, M., Mulligan, K., Grunfield, C., Daar, E.S., La Marca, A., Kotler, D.P., Wang, J., Bozzette, S.A. & Breitmeyer, J.B. (1996) Recombinant human growth hormone in patients with HIV-associated wasting: A randomised, placebo-controlled trial. Annals of Internal Medicine, 125, 873-882.
26. Takala, J., Ruokonen, E., Webster, N.R., Nielsen, M.S., Zandstra, D.F., Vundelinckx, G. & Hinds, C.J. (1999) Increased mortality associated with growth hormone treatment in critically ill adults. New England Journal of Medicine, 341, 785-792.
27. Teale, J.D. & Marks, V. (1986) The measurement of insulin-like growth factor I: Clinical applications and significance. Annals of Clinical Biochemistry, 23, 413-424.
28. Whitehead, H.M., Boreham, C., McIlrath, E.M., Sheridan, B., Kennedy, L., Atkinson, A.B. & Hadden, D.R. (1992) Growth hormone treatment of adults with growth hormone deficiency: Results of a 13-month placebo controlled cross-over study. Clinical Endocrinology, 36, 45-52.
29. Wilmore, D.W. (1991) Catabolic illness: Strategies for recovery. New England Journal of Medicine, 325, 695-702.
30. Zadik, Z., Chalew, S.A., McCarter, R.J., Meistas, M. & Kowarski, A.A. (1985) The influence of age on the 24-hour integrated secretion of growth hormone in normal individuals. Journal of Clinical Endocrinology and Metabolism, 60, 513-516.